Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083608

Options or other derivatives

  • Chief Financial Officer acquired 18,570 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick Chief Financial Officer 2026-02-26 Grant or award · Restricted Stock Units +18,570 18,570 D
Loading xslF345X05/ownership.xml…